Literature DB >> 18849324

Activation of sphingosine kinase-1 reverses the increase in lung vascular permeability through sphingosine-1-phosphate receptor signaling in endothelial cells.

Mohammad Tauseef1, Vidisha Kini, Nebojsa Knezevic, Melissa Brannan, Ram Ramchandaran, Henrik Fyrst, Julie Saba, Stephen M Vogel, Asrar B Malik, Dolly Mehta.   

Abstract

The lipid mediator sphingosine-1-phosphate (S1P), the product of sphingosine kinase (SPHK)-induced phosphorylation of sphingosine, is known to stabilize interendothelial junctions and prevent microvessel leakiness. Here, we investigated the role of SPHK1 activation in regulating the increase in pulmonary microvessel permeability induced by challenge of mice with lipopolysaccharide or thrombin ligation of protease-activating receptor (PAR)-1. Both lipopolysaccharide and thrombin increased mouse lung microvascular permeability and resulted in a delayed activation of SPHK1 that was coupled to the onset of restoration of permeability. In contrast to wild-type mice, Sphk1(-/-) mice showed markedly enhanced pulmonary edema formation in response to lipopolysaccharide and PAR-1 activation. Using endothelial cells challenged with thrombin concentration (50 nmol/L) that elicited a transient but reversible increase in endothelial permeability, we observed that increased SPHK1 activity and decreased intracellular S1P concentration preceded the onset of barrier recovery. Thus, we tested the hypothesis that released S1P in a paracrine manner activates its receptor S1P1 to restore the endothelial barrier. Knockdown of SPHK1 decreased basal S1P production and Rac1 activity but increased basal endothelial permeability. In SPHK1-depleted cells, PAR-1 activation failed to induce Rac1 activation but augmented RhoA activation and endothelial hyperpermeability response. Knockdown of S1P1 receptor in endothelial cells also enhanced the increase in endothelial permeability following PAR-1 activation. S1P treatment of Sphk1(-/-) lungs or SPHK1-deficient endothelial cells restored endothelial barrier function. Our results suggest the crucial role of activation of the SPHK1-->S1P-->S1P1 signaling pathway in response to inflammatory mediators in endothelial cells in regulating endothelial barrier homeostasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18849324      PMCID: PMC2708004          DOI: 10.1161/01.RES.0000338501.84810.51

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  39 in total

Review 1.  Sphingosine-1-phosphate signaling in endothelial activation.

Authors:  Harunobu Ozaki; Timothy Hla; Menq-Jer Lee
Journal:  J Atheroscler Thromb       Date:  2003       Impact factor: 4.928

2.  Cdc42 regulates the restoration of endothelial barrier function.

Authors:  Panos Kouklis; Maria Konstantoulaki; Stephen Vogel; Michael Broman; Asrar B Malik
Journal:  Circ Res       Date:  2003-12-04       Impact factor: 17.367

3.  Role of sphingosine-1 phosphate in the enhancement of endothelial barrier integrity by platelet-released products.

Authors:  Kane L Schaphorst; Eddie Chiang; Keri N Jacobs; Ari Zaiman; Viswanathan Natarajan; Frederick Wigley; Joe G N Garcia
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-03-07       Impact factor: 5.464

Review 4.  Role of coagulation inhibitors in inflammation.

Authors:  C T Esmon
Journal:  Thromb Haemost       Date:  2001-07       Impact factor: 5.249

5.  Abrogation of thrombin-induced increase in pulmonary microvascular permeability in PAR-1 knockout mice.

Authors:  S M Vogel; X Gao; D Mehta; R D Ye; T A John; P Andrade-Gordon; C Tiruppathi; A B Malik
Journal:  Physiol Genomics       Date:  2000-12-18       Impact factor: 3.107

Review 6.  Point-counterpoint of sphingosine 1-phosphate metabolism.

Authors:  Julie D Saba; Timothy Hla
Journal:  Circ Res       Date:  2004-04-02       Impact factor: 17.367

7.  Activation of endothelial cell protease activated receptor 1 by the protein C pathway.

Authors:  Matthias Riewald; Ramona J Petrovan; Aaron Donner; Barbara M Mueller; Wolfram Ruf
Journal:  Science       Date:  2002-06-07       Impact factor: 47.728

8.  Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation.

Authors:  Stuart M Pitson; Paul A B Moretti; Julia R Zebol; Helen E Lynn; Pu Xia; Mathew A Vadas; Binks W Wattenberg
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

9.  Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury.

Authors:  Xinqi Peng; Paul M Hassoun; Saad Sammani; Bryan J McVerry; Melissa J Burne; Hamid Rabb; David Pearse; Rubin M Tuder; Joe G N Garcia
Journal:  Am J Respir Crit Care Med       Date:  2004-03-12       Impact factor: 21.405

10.  Signaling pathways involved in sphingosine kinase activation and sphingosine-1-phosphate release in rat myometrium in late pregnancy: role in the induction of cyclooxygenase 2.

Authors:  Martin Serrano-Sanchez; Zahra Tanfin; Denis Leiber
Journal:  Endocrinology       Date:  2008-09       Impact factor: 4.736

View more
  104 in total

1.  The efficacy of activated protein C in murine endotoxemia is dependent on integrin CD11b.

Authors:  Chunzhang Cao; Yamei Gao; Yang Li; Toni M Antalis; Francis J Castellino; Li Zhang
Journal:  J Clin Invest       Date:  2010-05-10       Impact factor: 14.808

2.  Differential modulation of S1PR(1-5) and specific activities of SphK and nSMase in pulmonary and cerebral tissues of rats exposed to hypobaric hypoxia.

Authors:  Sonam Chawla; Shweta Saxena
Journal:  Lipids       Date:  2014-11-16       Impact factor: 1.880

3.  Free insulin-like growth factor binding protein-3 (IGFBP-3) reduces retinal vascular permeability in association with a reduction of acid sphingomyelinase (ASMase).

Authors:  Jennifer L Kielczewski; Sergio Li Calzi; Lynn C Shaw; Jun Cai; Xiaoping Qi; Qing Ruan; Lin Wu; Li Liu; Ping Hu; Tailoi Chan-Ling; Robert N Mames; Sue Firth; Robert C Baxter; Patric Turowski; Julia V Busik; Michael E Boulton; Maria B Grant
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-21       Impact factor: 4.799

Review 4.  Role of reactive oxygen and nitrogen species in the vascular responses to inflammation.

Authors:  Peter R Kvietys; D Neil Granger
Journal:  Free Radic Biol Med       Date:  2011-11-12       Impact factor: 7.376

5.  Isoflurane versus sevoflurane for early brain injury and expression of sphingosine kinase 1 after experimental subarachnoid hemorrhage.

Authors:  Orhan Altay; Hidenori Suzuki; Bilge Nur Altay; Vahit Calisir; Jiping Tang; John H Zhang
Journal:  Neurosci Lett       Date:  2020-06-06       Impact factor: 3.046

6.  Transient receptor potential channel 1 maintains adherens junction plasticity by suppressing sphingosine kinase 1 expression to induce endothelial hyperpermeability.

Authors:  Mohammad Tauseef; Mohammad Farazuddin; Sukriti Sukriti; Charu Rajput; James Otto Meyer; Suresh Kumar Ramasamy; Dolly Mehta
Journal:  FASEB J       Date:  2015-08-27       Impact factor: 5.191

Review 7.  The emerging alliance of sphingosine-1-phosphate signalling and immune cells: from basic mechanisms to implications in hypertension.

Authors:  Nicholas Don-Doncow; Yun Zhang; Hana Matuskova; Anja Meissner
Journal:  Br J Pharmacol       Date:  2018-07-03       Impact factor: 8.739

8.  Endogenous EPCR/aPC-PAR1 signaling prevents inflammation-induced vascular leakage and lethality.

Authors:  Frank Niessen; Christian Furlan-Freguia; José A Fernández; Laurent O Mosnier; Francis J Castellino; Hartmut Weiler; Hugh Rosen; John H Griffin; Wolfram Ruf
Journal:  Blood       Date:  2009-01-13       Impact factor: 22.113

9.  Role of IQGAP1 in endothelial barrier enhancement caused by OxPAPC.

Authors:  Yufeng Tian; Xinyong Tian; Grzegorz Gawlak; Nicolene Sarich; David B Sacks; Anna A Birukova; Konstantin G Birukov
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-08-26       Impact factor: 5.464

10.  Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice.

Authors:  Eric Camerer; Jean B Regard; Ivo Cornelissen; Yoga Srinivasan; Daniel N Duong; Daniel Palmer; Trung H Pham; Jinny S Wong; Rajita Pappu; Shaun R Coughlin
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.